
Related news and events
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
Admissions and credentials
New York
California
District of Columbia
Experience
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Related contacts
Related Practices & Industries
Ambiq Micro Announces Pricing of $96 Million IPO
July 30, 2025
Cooley advised Ambiq Micro, a technology leader in ultra-low-power semiconductor solutions for edge artificial intelligence, on its $96 million initial public offering (IPO).
Related contacts
Related Practices & Industries
Kudu Dynamics Announces $300 Million Sale to Leidos
May 28, 2025
Cooley advised Kudu Dynamics, a company developing state-of-the-art cyber capabilities and nonkinetic effects against a variety of military-relevant systems, on its sale to Leidos (NYSE: LDOS), an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations.
Related contacts
Related Practices & Industries
Takara Bio Announces Acquisition of Curio Bioscience
January 15, 2025
Cooley advised Takara Bio, a global biotechnology and life sciences company headquartered in Shiga, Japan, on its acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.